A new peer review publication provides further insights into the well-established efficacy of Menicon Bloom Night™ lenses for slowing myopia progression in children

Menicon Co., Ltd  is pleased to share the results of a new peer review paper that provides further support towards the safety of Menicon Bloom Night^TM lenses for slowing myopia progression in children.¹

Menicon Bloom Night^TM contact lens is the overnight lens wear offering for myopia management included in Menicon Bloom^TM Myopia Control Management System, a holistic approach for myopia control management. Menicon Bloom Night^TM is a CE-approved contact lens for the correction of refractive myopia and for myopia control, and is available in two different contact lens designs: Menicon Bloom Night™ and Menicon Bloom Night™ Toric.

The results from this new study, after being presented at various conferences worldwide, became available in full since June 20^th, 2024 as ahead of print in Contact Lens and Anterior Eye, the peer review journal of the British Contact Lens Association. The study, entitled ‘A new look at the myopia control efficacy of orthokeratology’, is available for free via Open Access. By pooling together data from three prospective studies, this new paper was able to identify several key findings related to the efficacy of overnight wear of Menicon Bloom Night^TM lenses in slowing myopia progression. Well in line with results reported in systematic reviews and meta-analyses, this study found that the use of these lenses provides a mean 2-years reduction in the axial elongation of the eye of 0.24mm in comparison to distance, single-vision spectacle lens wear, with over 60% of the treatment effect being obtained during the first year of treatment. The myopia control efficacy of Menicon Bloom Night^TM lenses was found to be independent of the patient’s age, gender, baseline refractive error and ethnicity indicating that their use provide similar levels of effectiveness in slowing myopia progression regardless of these factors. Finally, the study was able to quantify and categorize different levels of myopia control efficacy associated with orthokeratology contact lens wear. Although Menicon Bloom Night^TM lenses can successfully correct refractive error in most subjects (within the indications for use of the device), these lenses were somehow effective and not effective at all for myopia control in 75% and 25% of the lens wearers.

As orthokeratology is one of the most commonly used myopia control interventions currently available,² these results inform eye care professionals as to what sort of myopia control efficacy can be expected when Menicon Bloom Night^TMare prescribed for slowing myopia progression to myopic children.

Jacinto Santodomingo-Rubido, OD (EC), MSc, PhD, MCOptom, FBCLA, FAAO
The study’s main author and Menicon’s Clinical Affairs Manager and Senior Research Scientist

References

1. Santodomingo-Rubido J, Cheung SW, Villa-Collar C; ROMIO/MCOS/TO-SEE Groups. A new look at the myopia control efficacy of orthokeratology. Cont Lens Anterior Eye. 2024 Jun 20:102251. doi: 10.1016/j.clae.2024.102251. Epub ahead of print. PMID: 38906728.
2. Wolffsohn JS, Whayeb Y, Logan NS, Weng R; International Myopia Institute Ambassador Group*. IMI-Global Trends in Myopia Management Attitudes and Strategies in Clinical Practice-2022 Update. Invest Ophthalmol Vis Sci. 2023 May 1;64(6):6. doi: 10.1167/iovs.64.6.6. Erratum in: Invest Ophthalmol Vis Sci. 2023 May 1;64(5):12. doi: 10.1167/iovs.64.5.12. PMID: 37126357; PMCID: PMC10155870.